Aclaris Therapeutics
ACRS
$1.18
Share price
0.00%
Change (1 day)
-85.57%
Change (1 year)
Categories
Aclaris Therapeutics (ACRS) Fails to deliver data
Key failure to deliver metrics for Aclaris Therapeutics:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: $0.01 M
- Last 3 months FTD volume: $0.06 M
- Last year FTD volume: $2.19 M
Failures to deliver for Aclaris Therapeutics (ACRS) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Aclaris Therapeutics (ACRS) - since 2015
Volume in USD (price x number of shares), data since 2015Aclaris Therapeutics (ACRS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.12 M | -97.08% |
| 2023 | $4.44 M | 138.96% |
| 2022 | $1.86 M | -98.82% |
| 2021 | $0.15 B | 5540.04% |
| 2020 | $2.8 M | -10.83% |
| 2019 | $3.14 M | -24.41% |
| 2018 | $4.15 M | -88.34% |
| 2017 | $35.66 M | 1625.66% |
| 2016 | $2.06 M | -84.63% |
| 2015 | $13.44 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.05 M | $6.99 M | 🇺🇸 USA |